Add to a list

Inactive Instrument

Carmat Stock Other OTC

Medical Equipment, Supplies & Distribution

on all subscriptions*

Last days

Enjoy this offer

* See conditions under "Our services"

Analysts' recommendations: Carmat

25-05-09	Carmat: Invest Securities raises target price
25-04-11	Carmat: Invest Securities still a buyer, but cuts TP
25-02-04	Carmat: Invest Securities slightly lowers its target
25-01-09	Carmat: Invest Securities upgrades to buy
25-01-09	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages: Carmat

Mar. 04	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
Jan. 07	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
Jan. 07	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
Jan. 07	CARMAT : A suivre aujourd'hui
Jan. 07	Les records continuent à tomber en bourse

More news

Managers and Directors: Carmat

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	2016-08-31
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	2018-12-11
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	2025-03-31

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	2017-01-01
Michael Mack BRD	Director/Board Member	79	2017-04-19

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrows Top Investments!

SEIZE THE OFFER!

Market Cap	6.15M 7.12M 5.66M 5.3M 9.93M 676M 10.09M 66.87M 26.07M 329M 26.7M 26.14M 1.14B	P/E Ratio 2023	-3.09x	P/E Ratio 2024	-0.95x
Enterprise Value	59.25M 68.6M 54.6M 51.1M 95.77M 6.52B 97.25M 645M 251M 3.17B 257M 252M 10.99B	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

Jan. 07	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
Jan. 07	CARMAT: To Watch Today
Jan. 06	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
Jan. 06	Carmat Announces Liquidation and Delisting
Dec. 02	Only Takeover Bid for Carmat Approved by Court
Dec. 02	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
Dec. 02	Carmat receives takeover bid	RE
Nov. 04	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
25-10-15	CAC 40 Surges on LVMH Results and Easing US-China Tensions
25-10-15	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
25-10-15	Carmat says liquidation review postponed until Nov 25	RE
25-10-01	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE
25-10-01	Carmat: Judiciary administrator has submitted request to convert receivership into liquidation to court	RE

Dec. 02	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
Nov. 04	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
25-10-29	CARMAT : Inside Information / Other news releases	PU
25-10-29	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
25-10-15	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT	-.--%	-.--%	-	-	7.08M
STRYKER CORPORATION	+2.15%	+2.14%	-17.95%	+11.53%	120B
SMITH & NEPHEW PLC	-0.31%	-1.22%	+2.12%	-4.39%	12.9B
GLAUKOS CORPORATION	+2.05%	+1.45%	+29.93%	+89.47%	7.44B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+1.87%	-4.66%	-48.17%	-69.38%	4.2B
DOUBLE MEDICAL TECHNOLOGY INC.	+2.06%	+4.10%	+12.25%	+35.92%	2.55B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+5.46%	+10.04%	-16.99%	-13.15%	1.8B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+1.67%	-5.73%	+2.23%	-10.20%	1.66B
L&C BIO CO.,LTD	-8.89%	-10.79%	+152.55%	+124.20%	1.37B
Average	+0.67%	+0.88%	+14.50%	+20.50%	18.95B
Weighted average by Cap.	+1.86%	+1.76%	-12.45%	+12.66%

	2023	2024
Net sales	3.84M 4.44M 3.54M 3.31M 6.2M 422M 6.3M 41.75M 16.28M 206M 16.67M 16.32M 712M	7.34M 8.5M 6.77M 6.33M 11.87M 808M 12.06M 79.91M 31.16M 393M 31.91M 31.23M 1.36B
Net income	-53.87M -62.37M -49.64M -46.47M -87.08M -5.93B -88.43M -586M -229M -2.89B -234M -229M -9.99B	-51.4M -59.51M -47.36M -44.33M -83.08M -5.66B -84.37M -559M -218M -2.75B -223M -219M -9.53B
Net Debt	49.64M 57.47M 45.74M 42.81M 80.24M 5.46B 81.48M 540M 211M 2.66B 216M 211M 9.21B	53.1M 61.48M 48.93M 45.8M 85.84M 5.84B 87.17M 578M 225M 2.84B 231M 226M 9.85B

Carmat Stock Other OTC

Stocks

Medical Equipment, Supplies & Distribution

Valuation: Carmat

Latest news : Carmat

Analysts' recommendations: Carmat

Press Releases: Carmat

News in other languages: Carmat

Managers and Directors: Carmat

Medical Devices & Implants

Financials

Company Profile